Discover the detailed record of transactions filed by Kunin Audrey, Directeur Produit. Insider active across 1 companies, notably NovaBay Pharmaceuticals, Inc.. Aggregated, 10 filings have been recorded. Total volume traded: €362k. The latest transaction was filed on 3 December 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Audrey Kunin is the Chief Product Officer at NovaBay Pharmaceuticals, Inc. She oversees the development of new products and innovation within the company. Her expertise in research and development is essential for the success of the company's initiatives. Audrey is committed to improving patient outcomes through innovative solutions.